(+)-dexrazoxane decreases expression ISO RGD:1615097 6480464 Dexrazoxane results in decreased expression of ACSS1 mRNA CTD PMID:26873546 (+)-dexrazoxane multiple interactions ISO RGD:1615097 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of ACSS1 mRNA CTD PMID:26873546 1,1-dichloroethene decreases expression ISO RGD:1615097 6480464 vinylidene chloride results in decreased expression of ACSS1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1615097 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1615097 6480464 Estradiol results in increased expression of ACSS1 mRNA CTD PMID:15289156 17beta-estradiol decreases expression ISO RGD:1314754 6480464 Estradiol results in decreased expression of ACSS1 mRNA CTD PMID:31614463 17beta-estradiol multiple interactions ISO RGD:1314754 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ACSS1 mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1314754 6480464 2 more ... CTD PMID:31675489 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:1314754 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSS1 mRNA CTD PMID:33387578 2,4,6-tribromophenol increases expression ISO RGD:1314754 6480464 2 more ... CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1314754 6480464 tetrabromobisphenol A results in decreased expression of ACSS1 protein CTD PMID:31675489 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ACSS1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of ACSS1 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of ACSS1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1314754 6480464 Acrylamide results in decreased expression of ACSS1 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1314754 6480464 Aflatoxin B1 results in decreased expression of ACSS1 mRNA CTD PMID:32234424 aldehydo-D-glucose increases expression ISO RGD:1314754 6480464 Glucose results in increased expression of ACSS1 mRNA CTD PMID:36156098 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of ACSS1 mRNA CTD PMID:30779732 arsane multiple interactions ISO RGD:1615097 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS1 mRNA CTD PMID:32045263 arsenic atom multiple interactions ISO RGD:1615097 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS1 mRNA CTD PMID:32045263 arsenite(3-) increases methylation ISO RGD:1314754 6480464 arsenite results in increased methylation of ACSS1 promoter CTD PMID:23974009 benzo[a]pyrene increases expression ISO RGD:1615097 6480464 Benzo(a)pyrene results in increased expression of ACSS1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1314754 6480464 Benzo(a)pyrene results in decreased expression of ACSS1 mRNA, Benzo(a)pyrene results in decreased expression of ACSS1 protein CTD PMID:32234424 , PMID:33278487 benzo[a]pyrene affects methylation ISO RGD:1314754 6480464 Benzo(a)pyrene affects the methylation of ACSS1 promoter CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1314754 6480464 Benzo(a)pyrene results in increased methylation of ACSS1 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1615097 6480464 Benzo(a)pyrene results in decreased expression of ACSS1 mRNA CTD PMID:22610609 bisphenol A increases expression ISO RGD:1615097 6480464 bisphenol A results in increased expression of ACSS1 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1615097 6480464 bisphenol A results in decreased expression of ACSS1 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO RGD:1314754 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACSS1 gene CTD PMID:31601247 bisphenol A affects methylation ISO RGD:1314754 6480464 bisphenol A affects the methylation of ACSS1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1314754 6480464 bisphenol A results in decreased expression of ACSS1 protein CTD PMID:31675489 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ACSS1 gene CTD PMID:28505145 bisphenol A affects methylation ISO RGD:1615097 6480464 bisphenol A affects the methylation of ACSS1 promoter CTD PMID:27334623 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ACSS1 mRNA CTD PMID:25181051 carbon nanotube decreases expression ISO RGD:1615097 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1314754 6480464 CGP 52608 promotes the reaction [RORA protein binds to ACSS1 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1615097 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ACSS1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACSS1 mRNA CTD PMID:20938992 , PMID:29127188 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of ACSS1 mRNA CTD PMID:27899881 copper atom multiple interactions ISO RGD:1314754 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ACSS1 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of ACSS1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1314754 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ACSS1 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of ACSS1 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1314754 6480464 Copper Sulfate results in decreased expression of ACSS1 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ACSS1 mRNA CTD PMID:26577399 , PMID:27523638 D-glucose increases expression ISO RGD:1314754 6480464 Glucose results in increased expression of ACSS1 mRNA CTD PMID:36156098 decabromodiphenyl ether increases expression ISO RGD:1314754 6480464 decabromobiphenyl ether results in increased expression of ACSS1 protein CTD PMID:31675489 dextran sulfate multiple interactions ISO RGD:1615097 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS1 mRNA CTD PMID:29950665 dibutyl phthalate decreases expression ISO RGD:1615097 6480464 Dibutyl Phthalate results in decreased expression of ACSS1 mRNA CTD PMID:17361019 , PMID:21266533 diethylstilbestrol increases expression ISO RGD:1615097 6480464 Diethylstilbestrol results in increased expression of ACSS1 mRNA CTD PMID:15289156 dioxygen multiple interactions ISO RGD:1615097 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS1 mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ACSS1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1314754 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSS1 mRNA CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:1615097 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of ACSS1 mRNA, Doxorubicin affects the reaction [SIRT1 protein affects the acetylation of ACSS1 protein] CTD PMID:26873546 , PMID:31768571 doxorubicin decreases acetylation ISO RGD:1615097 6480464 Doxorubicin results in decreased acetylation of ACSS1 protein CTD PMID:31768571 doxorubicin decreases expression ISO RGD:1615097 6480464 Doxorubicin results in decreased expression of ACSS1 mRNA CTD PMID:26873546 ethanol increases expression ISO RGD:1615097 6480464 Ethanol results in increased expression of ACSS1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1615097 6480464 [1 more ... CTD PMID:20938992 more ... fulvestrant multiple interactions ISO RGD:1314754 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACSS1 gene CTD PMID:31601247 genistein increases expression ISO RGD:1615097 6480464 Genistein results in increased expression of ACSS1 mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ACSS1 mRNA CTD PMID:22061828 glucose increases expression ISO RGD:1314754 6480464 Glucose results in increased expression of ACSS1 mRNA CTD PMID:36156098 hydrogen peroxide affects expression ISO RGD:1314754 6480464 Hydrogen Peroxide affects the expression of ACSS1 mRNA CTD PMID:20044591 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA CTD PMID:22129741 L-methionine multiple interactions ISO RGD:1615097 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ACSS1 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACSS1 mRNA CTD PMID:20938992 , PMID:29127188 lead(0) decreases expression ISO RGD:1314754 6480464 Lead results in decreased expression of ACSS1 mRNA CTD PMID:19921347 leflunomide decreases expression ISO RGD:1314754 6480464 leflunomide results in decreased expression of ACSS1 mRNA CTD PMID:28988120 , PMID:29427785 lipopolysaccharide decreases expression ISO RGD:1314754 6480464 Lipopolysaccharides results in decreased expression of ACSS1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1314754 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACSS1 mRNA CTD PMID:35811015 MeIQx decreases expression ISO RGD:1314754 6480464 2-amino-3 more ... CTD PMID:20816883 menadione affects expression ISO RGD:1314754 6480464 Vitamin K 3 affects the expression of ACSS1 mRNA CTD PMID:20044591 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA CTD PMID:22129741 N-Nitrosopyrrolidine decreases expression ISO RGD:1314754 6480464 N-Nitrosopyrrolidine results in decreased expression of ACSS1 mRNA CTD PMID:32234424 O-methyleugenol decreases expression ISO RGD:1314754 6480464 methyleugenol results in decreased expression of ACSS1 mRNA CTD PMID:32234424 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of ACSS1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACSS1 mRNA CTD PMID:25729387 paracetamol decreases expression ISO RGD:1314754 6480464 Acetaminophen results in decreased expression of ACSS1 mRNA CTD PMID:25704631 , PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ACSS1 mRNA CTD PMID:32680482 perfluorohexanesulfonic acid increases expression ISO RGD:1615097 6480464 perfluorohexanesulfonic acid results in increased expression of ACSS1 mRNA CTD PMID:21705711 perfluorooctanoic acid increases expression ISO RGD:1615097 6480464 perfluorooctanoic acid results in increased expression of ACSS1 mRNA CTD PMID:30657992 pirinixic acid increases expression ISO RGD:1615097 6480464 pirinixic acid results in increased expression of ACSS1 mRNA CTD PMID:23811191 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1314754 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACSS1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1314754 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSS1 mRNA CTD PMID:27188386 sodium acetate trihydrate increases expression ISO RGD:1314754 6480464 Sodium Acetate results in increased expression of ACSS1 mRNA CTD PMID:36156098 sodium arsenite multiple interactions ISO RGD:1615097 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS1 mRNA CTD PMID:32045263 streptozocin multiple interactions ISO RGD:1615097 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of ACSS1 mRNA CTD PMID:29127188 sunitinib increases expression ISO RGD:1314754 6480464 Sunitinib results in increased expression of ACSS1 mRNA CTD PMID:31533062 tebuconazole decreases expression ISO RGD:1314754 6480464 tebuconazole results in decreased expression of ACSS1 mRNA CTD PMID:30458266 temozolomide increases expression ISO RGD:1314754 6480464 Temozolomide results in increased expression of ACSS1 mRNA CTD PMID:31758290 testosterone decreases expression ISO RGD:1615097 6480464 Testosterone results in decreased expression of ACSS1 mRNA CTD PMID:20403060 testosterone increases expression ISO RGD:1615097 6480464 Testosterone deficiency results in increased expression of ACSS1 mRNA CTD PMID:33848595 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of ACSS1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1615097 6480464 titanium dioxide results in decreased expression of ACSS1 mRNA CTD PMID:27760801 titanium dioxide multiple interactions ISO RGD:1615097 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS1 mRNA CTD PMID:29950665 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACSS1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of ACSS1 mRNA CTD PMID:25729387 tributylstannane increases expression ISO RGD:1615097 6480464 tributyltin results in increased expression of ACSS1 mRNA CTD PMID:31939706 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ACSS1 mRNA CTD PMID:33387578 trovafloxacin decreases expression ISO RGD:1615097 6480464 trovafloxacin results in decreased expression of ACSS1 mRNA CTD PMID:35537566 urethane decreases expression ISO RGD:1314754 6480464 Urethane results in decreased expression of ACSS1 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1615097 6480464 Valproic Acid results in increased expression of ACSS1 mRNA CTD PMID:21427059 valproic acid multiple interactions ISO RGD:1314754 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSS1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1314754 6480464 Valproic Acid results in increased expression of ACSS1 mRNA CTD PMID:23179753 , PMID:26272509 vancomycin increases expression ISO RGD:1615097 6480464 Vancomycin results in increased expression of ACSS1 mRNA CTD PMID:18930951 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of ACSS1 gene CTD PMID:31079544